发明名称 |
GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE |
摘要 |
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease. |
申请公布号 |
US2016130356(A1) |
申请公布日期 |
2016.05.12 |
申请号 |
US201614987432 |
申请日期 |
2016.01.04 |
申请人 |
Siamab Therapeutics, Inc. |
发明人 |
DeSander Julie;Behrens Jeffrey |
分类号 |
C07K16/30;A61K39/395;A61K47/02;A61K47/48;A61K47/12 |
主分类号 |
C07K16/30 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of reducing tumor volume comprising administering an antibody to a subject in need thereof, wherein said antibody is administered at a dose of from about 0.25 mg/kg to about 25 mg/kg and wherein said antibody comprises a variable domain having an amino acid sequence comprising at least 95% amino acid sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NOs: 15-52. |
地址 |
Newton MA US |